Laboratory tests performed in hip fracture patients. CTX: carboxy-terminal telopeptide of collagen I, PTH: parathyroid hormone, P1NP: procollagen type I N propeptide, U/A: urinalysis.|@|~(^,^)~|@|First-line treatment option for osteoporosis in hip fracture patients. BP: bisphosphonate, PTH: parathyroid hormone, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|Osteoporosis medication in patients with rebound phenomenon after cessation of denosumab. Ca+Vit. D: calcium and vitamin D, PTH: parathyroid hormone, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|The most important recognized factor for atypical femoral fracture.|@|~(^,^)~|@|Preferred osteoporosis medications after cessation of bisphosphonate in patients with atypical femoral fracture. PTH: parathyroid hormone, Ca+Vit. D: calcium and vitamin D, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|Preferred osteoporosis medications in patients with high-risk of atypical femoral fracture. Ca+Vit. D: calcium and vitamin D, SERM: selective estrogen receptor modulator, PTH: parathyroid hormone.

© H&P